{"nct_id":"NCT05048797","title":"A Study to Investigate the Efficacy and Safety of Trastuzumab Deruxtecan as the First Treatment Option for Unresectable, Locally Advanced/Metastatic Non-Small Cell Lung Cancer With HER2 Mutations","status":"RECRUITING","status_verified_date":"2025-08","start_date":"2021-10-28","start_date_type":"ACTUAL","primary_completion_date":"2026-03-31","primary_completion_date_type":"ESTIMATED","completion_date":"2027-07-30","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["AZN"]}